Steven Reichling, CHIEF FINANCIAL OFFICER at Accelerate Diagnostics, Inc (AXDX), bought 850 shares at $13.13 ($11K) on 2018-11-27, disclosed to the SEC on 2018-11-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| AXDX | SELL | 2023-02-15 | $3K | — | Filing → |
| AXDX | SELL | 2023-01-17 | $3K | — | Filing → |
| AXDX | BUY | 2022-08-22 | $7K | — | Filing → |